This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

How Tainted Food Can Make You Money

The growing number household products produced abroad has led Congress to consider various legislation that would appropriate further funding to the CPSC. Should these proposed new laws pass, food safety companies would be well positioned, as the implications of these developments extend beyond just household products.

With these developments in mind, Ratings found three companies in the food-safety market that not only have proven penetration in the space but also are ranked highly by our model.

Our proprietary model's affinity to companies that show solid upside potential is supported by a number of metrics, including growth, price movement, returns, volatility, fundamentals and overall financial strength. The companies below rank strongly across these metrics.

Neogen, our top performer, produces disposable, single-use, immunoassay and gene probe testing products that rely on the company's proprietary antibodies and RNA and DNA probes to produce rapid results.

These tests are used to detect dangerous and/or unintended substances in human food and animal feed, such as food-borne pathogens, spoilage organisms, natural toxins, food allergens, genetic modifications, ruminant byproducts, drug residues, pesticide residues and general sanitation concerns.

Currently ranked No. 14 among 731 stocks that we rate in the overall health care industry, and No. 5 out of 206 stocks rated within the health care equipment and supplies subsector, Neogen most recently earned an overall score of 7.70 (out of a possible 10), which translated into a strong buy rating.

Strategic Diagnostics' detection technologies allow industrial customers (through the use of antibodies) to rapidly identify the presence of pollutants such as chemical toxins, biological pathogens and other contaminants that can compromise human or environmental safety, and/or financially impact efficiencies of production processes.

The company most recently earned an overall score of 5.43, which translated into a decent buy rating.

Meridian Bioscience produces diagnostic test kits primarily for certain respiratory, gastrointestinal, viral and parasitic infectious diseases. The company also manufactures and distributes bulk antigens, antibodies and reagents for use by researchers and other diagnostic manufacturers.

The company most recently earned an overall score of 6.89, which reflects a solid buy rating.

Also of note, many larger biotechnology and life science companies have been applying their existing products and technology to create new solutions across different verticals. These companies include drug giants like Pfizer (PFE) and Johnson & Johnson (JNJ - Get Report), as well as mid-cap companies such as Applied Biosystems, Millipore and PerkinElmer.
This article was written by a staff member of Ratings.
2 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
ABI $22.98 1.01%
MIL $1.85 3.01%
JNJ $112.08 0.00%
NEOG $47.24 0.00%
PFI $29.45 0.00%


Chart of I:DJI
DOW 17,773.64 -57.12 -0.32%
S&P 500 2,065.30 -10.51 -0.51%
NASDAQ 4,775.3580 -29.9330 -0.62%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs